Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Penederm and Alpharma enter marketing agreement

Feb. 5, 1998

New anti-PCP agent is more potent than pentamidine

Feb. 5, 1998

Salivary peptide fragment may be useful for oral candidiasis

Feb. 5, 1998

Favorable clinical safety, pharmacokinetics and anti-CMV activity reported for 1263W94

Feb. 5, 1998

Glaxo Wellcome characterizes in vitro/in vivo antibacterial activity of new trinem

Feb. 4, 1998

Shaman suspends phase II trial of Virend

Feb. 3, 1998

Trovan soon to be available in pharmacies

Feb. 3, 1998

Topical interferon alfa enters phase II for intravaginal warts

Feb. 2, 1998

RiboGene and Dainippon join forces in antibacterial collaboration

Feb. 2, 1998

Roche discloses inhibitors of bacterial dihydrofolate reductase

Feb. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...